A prospective, open, multicentre study to evaluate a new gelling fibre dressing containing silver in the management of venous leg ulcers
- PMID: 24602074
- PMCID: PMC4674970
- DOI: 10.1111/iwj.12239
A prospective, open, multicentre study to evaluate a new gelling fibre dressing containing silver in the management of venous leg ulcers
Abstract
This study investigated the performance of a new gelling fibre dressing containing silver (DURAFIBER™ Ag; Smith & Nephew, Hull, UK) in moderate to highly exuding venous leg ulcers with one or more clinical signs of infection. Fourteen patients with venous leg ulceration of median ulcer duration 12·5 weeks, recruited from three centres in South Africa, received treatment with the new dressing for a maximum of 8 weeks. Multilayer compression bandaging was used for all patients, at the majority of assessments. The objectives of this study were to assess the clinical acceptability of the dressing in terms of the following characteristics: antimicrobial properties, the progress of the wound towards healing, wear time, exudate management, conformability, patient comfort, pain on application, pain on removal and dressing integrity. The new dressing was rated as clinically acceptable for all characteristics, for all 14 patients (100%). It was easy to apply and remove; in 96·8% of removals, the dressing stayed intact on removal and could be removed in one piece. Fifty per cent of the wounds healed within the 8-week study duration; between baseline and final assessment, the median percentage reduction in wound area was 98·2% and the median percentage reduction in devitalised tissue was 78%. Exudate levels and wound pain were significantly improved at final assessment compared to baseline assessment, and an increase in the number of patients with healthy peri-wound skin between baseline and final assessment was observed. A reduction in bioburden and signs of clinical infection and an improvement in quality of life were observed over the 8-week period. The average wear time was 6·4 days. This study supports the use of new dressing in the management of moderately to highly exuding venous leg ulcers with clinical signs of infection.
Keywords: Antimicrobial; Chronic wound; Dressing; Exudate; Infection.
© 2014 The Authors. International Wound Journal © 2014 Medicalhelplines.com Inc and John Wiley & Sons Ltd.
Figures
Similar articles
-
Use of a gelling fibre dressing in complex surgical or chronic wounds: a case series.J Wound Care. 2018 Jul 2;27(7):444-454. doi: 10.12968/jowc.2018.27.7.444. J Wound Care. 2018. PMID: 30016138
-
Clinical performance of a new silver dressing, Contreet Foam, for chronic exuding venous leg ulcers.J Wound Care. 2003 Oct;12(9):351-4. doi: 10.12968/jowc.2003.12.9.26534. J Wound Care. 2003. PMID: 14601228 Clinical Trial.
-
Evaluation of a silver-releasing hydroalginate dressing in chronic wounds with signs of local infection.J Wound Care. 2005 Oct;14(9):411-9. doi: 10.12968/jowc.2005.14.9.26835. J Wound Care. 2005. PMID: 16240620 Clinical Trial.
-
Protease-modulating matrix treatments for healing venous leg ulcers.Cochrane Database Syst Rev. 2016 Dec 15;12(12):CD011918. doi: 10.1002/14651858.CD011918.pub2. Cochrane Database Syst Rev. 2016. PMID: 27977053 Free PMC article. Review.
-
Antibiotics and antiseptics for venous leg ulcers.Cochrane Database Syst Rev. 2013 Dec 23;(12):CD003557. doi: 10.1002/14651858.CD003557.pub4. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2014 Jan 10;(1):CD003557. doi: 10.1002/14651858.CD003557.pub5 PMID: 24363048 Updated. Review.
Cited by
-
The diagnosis of infection in chronic leg ulcers: A narrative review on clinical practice.Int Wound J. 2019 Jun;16(3):601-620. doi: 10.1111/iwj.13069. Epub 2019 Jan 29. Int Wound J. 2019. PMID: 30697930 Free PMC article. Review.
-
The Management of Critically Colonized and Locally Infected Leg Ulcers with an Acid-Oxidizing Solution: A Pilot Study.Adv Skin Wound Care. 2018 Apr;31(4):163-171. doi: 10.1097/01.ASW.0000530687.23867.bd. Adv Skin Wound Care. 2018. PMID: 29561341 Free PMC article.
-
Immune Regulation of Skin Wound Healing: Mechanisms and Novel Therapeutic Targets.Adv Wound Care (New Rochelle). 2018 Jul 1;7(7):209-231. doi: 10.1089/wound.2017.0761. Adv Wound Care (New Rochelle). 2018. PMID: 29984112 Free PMC article. Review.
References
-
- Posnett J, Gottrup F, Lundgren H, Saal G. The resource impact of wounds on health‐care providers in Europe. J Wound Care 2009;18:154–61. - PubMed
-
- Cooper R. European Wound Management Association (EWMA). Position document: identifying criteria for wound infection. London: MEP Ltd, 2005.
-
- Wounds UK. Best practice statement: the use of topical antiseptic/antimicrobial agents in wound management. Aberdeen: Wounds UK, 2010.
-
- Cutting KF, White R. Defined and refined: criteria for identifying wound infection revisited. Br J Community Nurs 2004;9:S6–15. - PubMed
-
- Collier M. Recognition and management of wound infections. Worldwidewounds, 2004. [WWW document]. URL http://www.worldwidewounds.com [accessed on 15 June 2013]
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources